NCT02194738 2026-03-18
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
Phase NA Active not recruiting
Clinical Trials
6 trialsNCT04924374 2024-09-26
Microbiota Transplant in Advanced Lung Cancer Treated With Immunotherapy
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Phase NA Completed
NCT03769129 2024-06-25
Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
Second Affiliated Hospital of Guangzhou Medical University
Phase NA Recruiting
NCT06000358 2023-08-21
LUCACRIMUNO
Lithuanian University of Health Sciences
Phase NA Recruiting
NCT04793815 2023-06-29
Lung Cancer Cryo-Activation as a Novel Approach to Augment Immunotherapy Efficacy (CRYOVATE)
Centre hospitalier de l'Université de Montréal (CHUM)
Phase NA Completed
NCT04393883 2020-11-30
A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Unknown